Behavioral impact of sickle cell disease in young children with repeated hospitalization

Mohamed H Bakri1, Eman A Ismail1, Ghada O Elsedfy2

  • 1Department of Anesthesia, Children's Hospital, Faculty of Medicine, Assiut University, Egypt.

Insights

Children with sickle cell disease (SCD) experience significant behavioral issues, including anxiety and aggression, compared to healthy peers. Early intervention with psychological support and pain management is crucial for these children.

Area of Science:

  • Pediatric Psychology
  • Hematology
  • Child Development

Background:

  • Sickle cell disease (SCD) significantly impacts children's psychological well-being, especially those with repeated hospitalizations.
  • Parental distress and anxiety are common due to the challenges of managing SCD in children.
  • The psychological state of both children with SCD and their families is negatively affected.

Purpose of the Study:

  • To assess the behavioral impact of SCD in young children (1½ to 5 years) with a history of repeated hospitalizations.
  • To compare the behavior of children with SCD to a control group of healthy children.
  • To identify specific behavioral changes associated with SCD in early childhood.

Main Methods:

  • A study group of 35 children with SCD and repeated hospitalizations was matched with 35 healthy children.
  • The Child Behavior Checklist (CBCL) and a DSM-oriented scale were administered to assess behavior.
  • Behavioral data were collected using semi-structured questionnaires.

Main Results:

  • Children with SCD exhibited statistically significant increases in anxiety/depression, somatic complaints, withdrawal, and aggressive behavior compared to controls.
  • Internalizing symptoms were significantly higher in children with SCD.
  • Children with SCD scored significantly higher on the DSM scale for pervasive developmental disorder.

Conclusions:

  • Children with SCD and a history of repeated hospitalizations are at a higher risk for behavioral problems.
  • Psychological counseling and social support are recommended to mitigate behavioral consequences.
  • Effective pain management is essential in addressing the behavioral challenges faced by children with SCD.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
393
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
39.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
9.5K